These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36115672)

  • 1. Minimal disease activity and remission in patients with psoriatic arthritis with elevated body mass index: an observational cohort study in the Swiss Clinical Quality Management cohort.
    Vallejo-Yagüe E; Burkard T; Micheroli R; Burden AM
    BMJ Open; 2022 Sep; 12(9):e061474. PubMed ID: 36115672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index: a cohort study in a Swiss registry.
    Vallejo-Yagüe E; Burkard T; Finckh A; Burden AM;
    BMJ Open; 2024 Feb; 14(2):e074864. PubMed ID: 38331859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Composite Indices Tailored for Psoriatic Arthritis Treated with csDMARD and bDMARD: A Cross-sectional Analysis of a Longitudinal Cohort.
    Lubrano E; De Socio A; Perrotta FM
    J Rheumatol; 2017 Aug; 44(8):1159-1164. PubMed ID: 28572467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Different Remission and Low Disease Definitions in Psoriatic Arthritis and Evaluation of Their Prognostic Value.
    Coates LC; Gottlieb AB; Merola JF; Boone C; Szumski A; Chhabra A
    J Rheumatol; 2019 Feb; 46(2):160-165. PubMed ID: 30323006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis.
    Eder L; Thavaneswaran A; Chandran V; Cook RJ; Gladman DD
    Ann Rheum Dis; 2015 May; 74(5):813-7. PubMed ID: 24431392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower odds of remission among women with rheumatoid arthritis: A cohort study in the Swiss Clinical Quality Management cohort.
    Vallejo-Yagüe E; Pfund JN; Burkard T; Clair C; Micheroli R; Möller B; Finckh A; Burden AM
    PLoS One; 2022; 17(10):e0275026. PubMed ID: 36264948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriatic arthritis: improvement in outcomes but persistent sex difference - 5-year follow-up study of a Norwegian outpatient clinic population.
    Łosińska K; Michelsen B; Kavanaugh A; Korkosz M; Haugeberg G
    Scand J Rheumatol; 2024 Jan; 53(1):10-20. PubMed ID: 37656147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Composite Measure Remission Targets in Psoriatic Arthritis.
    Farkas F; Ikumi N; Elmamoun M; Szentpetery A; FitzGerald O
    J Rheumatol; 2021 Aug; 48(8):1272-1278. PubMed ID: 33722944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Should Be the Primary Target of "Treat to Target" in Psoriatic Arthritis?
    Coates LC; Lubrano E; Perrotta FM; Emery P; Conaghan PG; Helliwell PS
    J Rheumatol; 2019 Jan; 46(1):38-42. PubMed ID: 30219765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of Psoriatic Arthritis According to Different Definitions of Disease Activity: Comparing Minimal Disease Activity and the Disease Activity Index for Psoriatic Arthritis.
    Wervers K; Vis M; Tchetveriko I; Gerards AH; Kok MR; Appels CWY; van der Graaff WL; van Groenendael JHLM; Korswagen LA; Veris-van Dieren JJ; Hazes JMW; Luime JJ
    Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1764-1770. PubMed ID: 29609220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis.
    Iannone F; Nivuori M; Fornaro M; Venerito V; Cacciapaglia F; Lopalco G
    Rheumatology (Oxford); 2020 Jul; 59(7):1599-1606. PubMed ID: 31652315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results.
    Smolen JS; Siebert S; Korotaeva TV; Selmi C; Bergmans P; Gremese E; Joven-Ibáñez B; Katsifis G; Noël W; Nurmohamed MT; Richette P; Sfikakis PP; de Vlam K; Theander E; Gossec L
    Ann Rheum Dis; 2021 Nov; 80(11):1419-1428. PubMed ID: 34162594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis.
    Queiro R; Cañete JD; Montilla C; Abad MA; Montoro M; Gómez S; Cábez A;
    J Rheumatol; 2019 Jul; 46(7):710-715. PubMed ID: 30709957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs.
    Perrotta FM; Marchesoni A; Lubrano E
    J Rheumatol; 2016 Feb; 43(2):350-5. PubMed ID: 26669925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofacitinib studies.
    Schneeberger EE; Citera G; Nash P; Smolen JS; Mease PJ; Soriano ER; Helling C; Szumski AE; Mundayat R; de León DP
    Semin Arthritis Rheum; 2023 Feb; 58():152134. PubMed ID: 36476498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of body weight on the achievement of minimal disease activity in patients with rheumatic diseases: a systematic review and meta-analysis.
    Lupoli R; Pizzicato P; Scalera A; Ambrosino P; Amato M; Peluso R; Di Minno MN
    Arthritis Res Ther; 2016 Dec; 18(1):297. PubMed ID: 27964760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population.
    Michelsen B; Diamantopoulos AP; Høiberg HK; Soldal DM; Kavanaugh A; Haugeberg G
    J Rheumatol; 2017 Apr; 44(4):431-436. PubMed ID: 28148701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Response to Treatment, Remission, and Minimal Disease Activity in Axial Psoriatic Arthritis Treated with Tumor Necrosis Factor Inhibitors.
    Lubrano E; Parsons WJ; Perrotta FM
    J Rheumatol; 2016 May; 43(5):918-23. PubMed ID: 26980581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries.
    Gorlier C; Orbai AM; Puyraimond-Zemmour D; Coates LC; Kiltz U; Leung YY; Palominos P; Cañete JD; Scrivo R; Balanescu A; Dernis E; Tälli S; Ruyssen-Witrand A; Soubrier M; Aydin SZ; Eder L; Gaydukova I; Lubrano E; Kalyoncu U; Richette P; Husni ME; de Wit M; Smolen JS; Gossec L
    Ann Rheum Dis; 2019 Feb; 78(2):201-208. PubMed ID: 30442648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overweight, Obesity, and the Likelihood of Achieving Sustained Remission in Early Rheumatoid Arthritis: Results From a Multicenter Prospective Cohort Study.
    Schulman E; Bartlett SJ; Schieir O; Andersen KM; Boire G; Pope JE; Hitchon C; Jamal S; Thorne JC; Tin D; Keystone EC; Haraoui B; Goodman SM; Bykerk VP;
    Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1185-1191. PubMed ID: 29193840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.